Nyumbani › Multiple Myeloma › Florida › Tampa
Majaribio ya kliniki ya Multiple Myeloma katika Tampa, FL
Masomo 15 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Tampa na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
InaajiriHatua 1
- Moffitt Cancer Center /ID# 279068, Tampa
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
InaajiriHatua 3
- Research Site, Tampa
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 3
- Moffit Cancer center, Tampa
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
InaajiriHatua 4
- Moffitt Cancer Center, Tampa
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
InaajiriHatua 1
- Moffitt Cancer Center, Tampa
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 2
- Moffitt Cancer Center, Tampa
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
InaajiriHatua 1
- Moffitt Cancer Center, Tampa
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 1/2
- Research Site, Tampa
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
InaajiriHatua 1/2
- Research Site, Tampa
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
InaajiriHatua 3
- Research Site, Tampa
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
InaajiriHatua 1/2
- Moffitt Cancer Center /ID# 272628, Tampa
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
InaajiriHatua 3
- Moffitt at Memorial Healthcare System, Tampa
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 1/2
- Moffitt Cancer Center - McKinley Drive, Tampa
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
InaajiriHatua 1/2
- Moffitt Cancer Center, Tampa
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
InaajiriHatua 1
- Moffitt Cancer Center, Tampa
Majaribio ya Multiple Myeloma katika miji mingine
- New York City, NYUtafiti 60
- Boston, MAUtafiti 42
- Atlanta, GAUtafiti 41
- Houston, TXUtafiti 38
- Durham, NCUtafiti 37
- Nashville, TNUtafiti 32
- Denver, COUtafiti 27
- Rochester, MNUtafiti 24
- St. Louis, MOUtafiti 24
- Columbus, OHUtafiti 24
- Baldwin Park, CAUtafiti 23
- Chicago, ILUtafiti 22
Masomo mengine katika Tampa
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 51
- Saratani ya MatitiUtafiti 43
- Saratani (aina zote)Utafiti 39
- Kansari ya kolorektaliUtafiti 33
- Saratani ya MetastasiUtafiti 29
- Saratan ya MapafuUtafiti 29
- Leukemia ya Myeloid ya GhaflaUtafiti 29
- Kansari ya PancreasUtafiti 26
- Kansari ya MayaiUtafiti 21
- Sindromu za MyelodysplasticUtafiti 19
- MelanomaUtafiti 19
- Kushindwa kwa MoyoUtafiti 18
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.